Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Endometrial Neoplasms 5Anorexia 3Weight Loss 2Endometrial Hyperplasia 2Cachexia 2Breast Neoplasms 2Body Weight 2Squamous Intraepithelial Lesions 1Recurrence 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Body Weight Changes 1

Interventions

Megestrol Acetate 2exemestane 1Pterocarpus marsupium 1Pharmacogenomic Variants 13,5-dimethoxy-4'-hydroxystilbene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Endometrial Hyperplasia × Megestrol Acetate × Clear all
NCT03671811 2026-06-03

Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy

City of Hope Medical Center

Phase 2 Active not recruiting
44 enrolled 12 charts
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT00483327 2018-04-04

Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate

NYU Langone Health

Phase 2 Completed
31 enrolled 9 charts
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡